| PEB0191 | Validation of D:A:D Chronic kidney disease risk score model among people living with HIV in Asia | E-poster | B20 |
| PEB0192 | TDF renal safety in HBV-infected, HIV-negative women during pregnancy and post-partum period | E-poster | B20 |
| OAB0602 | Weight gain and hyperglycemia during the dolutegravir transition in Africa | Oral abstract session with live Q&A | B21 |
| PEB0193 | A study of effect of Anti-Retroviral Therapy (ART) regimen on Metabolic Syndrome (MetS) in people living with HIV/AIDS (PLHIV) in India: A comprehensive post hoc analysis | E-poster | B21 |
| OAB0603 | Changes in body mass index over time in persons with and without HIV | Oral abstract session with live Q&A | B22 |
| OAB0604 | Weight gain before and after switch from TDF to TAF | Oral abstract session with live Q&A | B22 |
| OAB0605 | Weight changes after switching to doravirine/lamivudine/TDF in the DRIVE-SHIFT trial | Oral abstract session with live Q&A | B22 |
| PEB0194 | Weight/body mass index (BMI) gains following initiation of integrase strand transfer inhibitor (INSTI) versus protease inhibitor (PI) among people living with human immunodeficiency virus (PLWH) in the United States | E-poster | B22 |
| PEB0195 | So much to lose: A review of 25 bariatric surgery cases in people living with HIV (PLWH) at an urban, Ryan White-funded HIV clinic | E-poster | B22 |
| PEB0196 | Impact of weight gain on prescribing behavior for HIV patients on integrase inhibitor regimens using real world data | E-poster | B22 |